+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eczema Therapeutics Market by Treatment Type (Phototherapy, Systemic, Topical), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Product Type, Formulation, End User - Global Forecast 2025-2030- Product Image
Eczema Therapeutics Market by Treatment Type (Phototherapy, Systemic, Topical), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Product Type, Formulation, End User - Global Forecast 2025-2030- Product Image
Sale

Eczema Therapeutics Market by Treatment Type (Phototherapy, Systemic, Topical), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Product Type, Formulation, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674454
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The eczema therapeutics market is experiencing a significant evolution, marked by innovation in treatment approaches, technology integration, and increasing emphasis on patient-centric solutions. Senior executives seeking actionable insights will find this analysis invaluable for understanding current drivers, future opportunities, and competitive dynamics.

Market Snapshot: Eczema Therapeutics Market Size & Growth Trends

The Eczema Therapeutics Market grew from USD 7.49 billion in 2024 to USD 8.24 billion in 2025. It is expected to continue growing at a CAGR of 9.67%, reaching USD 13.04 billion by 2030. Robust scientific advances, changing regulatory expectations, and dynamic patient needs are set to propel growth, with biologics, small molecule inhibitors, and digital health platforms shaping a more diverse treatment landscape. Leading players are adapting to new care models and accelerating real-world evidence generation to substantiate product value.

Scope & Segmentation

  • Treatment Types: Phototherapy, systemic therapies (biologics, Janus kinase inhibitors), topical treatments (OTC options such as anti-itch lotions, barrier repair creams, emollients, and prescriptions like calcineurin inhibitors, corticosteroids, PDE4 inhibitors)
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Product Types: Over-the-counter (OTC), prescription
  • Formulations: Creams, gels, lotions, ointments
  • End Users: Adult, pediatric
  • Geographies: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (20+ countries including UK, Germany, France, Saudi Arabia, South Africa), Asia-Pacific (China, India, Japan, Australia, South Korea, and more)
  • Key Companies: Sanofi S.A., Regeneron Pharmaceuticals, AbbVie, Pfizer, Eli Lilly, Novartis, Johnson & Johnson, LEO Pharma, Galderma, Viatris

Key Takeaways for Senior Decision-Makers

  • Biologics and targeted small molecule therapies are redefining standards for moderate-to-severe cases, increasing specialty focus and value-driven product pipelines.
  • Advanced topical agents now bridge the gap between prescription efficacy and OTC convenience, broadening patient access and personalizing regimens.
  • Digital health integration improves patient adherence, symptom tracking, and real-world data capture, informing both clinical development and payer negotiations.
  • Cross-sector partnerships—between pharmaceutical companies and technology providers—are accelerating portfolio innovation and facilitating novel monitoring solutions.
  • Diversification of distribution channels, especially the rise of online and direct-to-patient models, supports wider market coverage and tailored patient support.
  • Regional developments highlight varied regulatory and reimbursement frameworks; companies must adapt strategies by geography to optimize launch and access.

Tariff Impact: United States Policy Shifts in 2025

New U.S. tariff measures in 2025 have influenced sourcing and cost structures for eczema therapies. Import duties on pharmaceutical ingredients and excipients are prompting manufacturers to reevaluate vendor partnerships and move certain production activities closer to end markets. Enhanced border checks and compliance demands have extended lead times, driving shifts in inventory management and risk planning. Investment into domestic production and alternative supply arrangements is supporting market stability and improving resilience.

Methodology & Data Sources

This report combines exhaustive secondary research—including scientific journals, regulatory filings, and industry publications—with interviews from dermatology experts, payers, and patient advocacy leaders. Quantitative data modeling and qualitative synthesis ensure comprehensive coverage, while multi-source triangulation validates all insights and mitigates bias for industry clarity.

Why This Report Matters

  • Enables robust strategic planning by revealing evolving treatment pathways and emerging technologies in eczema therapeutics.
  • Provides regionally tailored intelligence to refine go-to-market and pricing strategies across diverse regulatory and payer environments.
  • Delivers actionable supply chain and portfolio recommendations, supporting executive decision-making on investment and partnership opportunities.

Eczema Therapeutics Market: Conclusion

The eczema therapeutics market is poised for continued innovation as stakeholders embrace technology, diversify portfolios, and advance patient engagement. This analysis equips decision-makers to anticipate industry shifts, strengthen competitive positioning, and drive patient-centered growth strategies.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of topical Janus kinase inhibitors driven by strong efficacy in moderate to severe eczema
5.2. Expansion of microbiome modulation therapies targeting skin barrier restoration in atopic eczema management
5.3. Growing investment in non steroidal peptide based topical formulations to minimize adverse effects in children with eczema
5.4. Integration of teledermatology platforms and AI diagnostic tools to personalize eczema treatment pathways
5.5. Increasing payer reimbursement restrictions driving price negotiations and market access strategies for biologics
5.6. Emergence of wearable drug delivery devices offering controlled release of therapeutics for chronic eczema patients
5.7. Development of precision medicine approaches using genetic biomarkers to predict patient response to eczema therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Eczema Therapeutics Market, by Treatment Type
8.1. Introduction
8.2. Phototherapy
8.3. Systemic
8.3.1. Biologics
8.3.2. Janus Kinase Inhibitors
8.4. Topical
8.4.1. OTC
8.4.1.1. Anti-Itch Lotions
8.4.1.2. Barrier Repair Creams
8.4.1.3. Emollients
8.4.2. Prescription
8.4.2.1. Calcineurin Inhibitors
8.4.2.2. Corticosteroids
8.4.2.3. Pde4 Inhibitors
9. Eczema Therapeutics Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Eczema Therapeutics Market, by Product Type
10.1. Introduction
10.2. OTC
10.3. Prescription
11. Eczema Therapeutics Market, by Formulation
11.1. Introduction
11.2. Creams
11.3. Gels
11.4. Lotions
11.5. Ointments
12. Eczema Therapeutics Market, by End User
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Americas Eczema Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Eczema Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Eczema Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sanofi S.A.
16.3.2. Regeneron Pharmaceuticals, Inc.
16.3.3. AbbVie Inc.
16.3.4. Pfizer Inc.
16.3.5. Eli Lilly and Company
16.3.6. Novartis AG
16.3.7. Johnson & Johnson
16.3.8. LEO Pharma A/S
16.3.9. Galderma S.A.
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ECZEMA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ECZEMA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ECZEMA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ECZEMA THERAPEUTICS MARKET: RESEARCHAI
FIGURE 26. ECZEMA THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. ECZEMA THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 28. ECZEMA THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ECZEMA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY JANUS KINASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY JANUS KINASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY ANTI-ITCH LOTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY ANTI-ITCH LOTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY BARRIER REPAIR CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY BARRIER REPAIR CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY EMOLLIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY EMOLLIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY LOTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ECZEMA THERAPEUTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ECZEMA THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 115. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 117. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 118. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 119. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 120. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 121. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 122. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 123. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 124. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 125. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ECZEMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 227. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 228. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 229. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 230. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 231. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 232. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 233. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. GERMANY ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 244. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 245. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 246. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 247. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 248. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 249. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 250. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 251. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 252. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 253. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 258. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 259. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. FRANCE ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 280. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 281. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 282. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 283. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 284. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 285. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 286. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 287. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 288. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 289. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 294. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 295. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ITALY ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 300. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 301. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 302. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 303. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 304. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 305. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 306. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 307. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 312. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 313. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SPAIN ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES ECZEMA THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY OTC, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA ECZEMA THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA ECZEMA THERAPEUTICS MARK

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Eczema Therapeutics market report include:
  • Sanofi S.A.
  • Regeneron Pharmaceuticals, Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Johnson & Johnson
  • LEO Pharma A/S
  • Galderma S.A.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.04 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Chronic Hand Eczema Market: Focus on Type, Treatment Type, and Country Analysis - Analysis and Forecast, 2025-2035 - Product Image

Chronic Hand Eczema Market: Focus on Type, Treatment Type, and Country Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Eczema Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Eczema Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Eczema Drug Pipeline Analysis Report 2025 - Product Image

Eczema Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Seborrheic Eczema - Pipeline Insight, 2025 - Product Image

Seborrheic Eczema - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2025 - Product Image

Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • 280 Pages
  • Global
From

About the Eczema Drug Market

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition. Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.